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One sentence summary: The success of using marine resources for the development of industrial products and processes depends on the manner they
are screened, produced and tested on a larger scale.
Editor: Michael Sauer
ABSTRACT
A global census of marine microbial life has been underway over the past several decades. During this period, there have
been scientific breakthroughs in estimating microbial diversity and understanding microbial functioning and ecology. It is
estimated that the ocean, covering 71% of the earth’s surface with its estimated volume of about 2 × 1018 m3 and an average
depth of 3800 m, hosts the largest population of microbes on Earth. More than 2 million eukaryotic and prokaryotic species
are thought to thrive both in the ocean and on its surface. Prokaryotic cell abundances can reach densities of up to 1012 cells
per millilitre, exceeding eukaryotic densities of around 106 cells per millilitre of seawater. Besides their large numbers and
abundance, marine microbial assemblages and their organic catalysts (enzymes) have a largely underestimated value for
their use in the development of industrial products and processes. In this perspective article, we identified critical gaps in
knowledge and technology to fast-track this development. We provided a general overview of the presumptive microbial
assemblages in oceans, and an estimation of what is known and the enzymes that have been currently retrieved. We also
discussed recent advances made in this area by the collaborative European Horizon 2020 project ‘INMARE’.
Keywords: biodiversity; enzyme; biotechnology; marine diversity; omics
INTRODUCTION
The ocean is one of the greatest unexplored frontiers to hu-
mankind. From extremely high pressures in the deepest parts of
the ocean to normal atmospheric pressure on the surface, from
temperatures above 300◦C in hydrothermal vents to sub-zero
temperatures in sea ice, and from low-salinity conditions to salt-
saturated brines, this environment, providing a range of condi-
tions often hostile to many life forms, accommodates diverse
communities ofmicroorganisms that have adapted to such chal-
lenging settings. The metabolic diversity of these microorgan-
isms promises a source of enzymes able to perform uniquely
in industrial settings where harsh physical and chemical con-
ditions are encountered (Harrison et al. 2013).
The market for industrial enzymes for non-therapeutic uses
(foods, detergents, textiles, pulp and paper) has doubled over
the past 15 years and has been recently estimated to be in
the region of US$4 billion per annum (Evans 2013). In 2019, a
turnover of about US$10 billion is expected with the produc-
tion of industrial enzymes through the application of bulk en-
zymes in different market sectors with growing demand. In ad-
dition to this, up to 40% of the chemical synthesis processes that
require environmentally damaging bulk organic solvents and
high-energy inputs could employ enzymatic catalysis by 2030,
creating a huge demand for new industrially relevant enzymes
(Martı´nez-Martı´nez, Bargiela and Ferrer 2017). Rapid technolog-
ical advances in omics and bioinformatics have revolutionised
the exploration of nature’s microbial diversity for industrially
relevant enzymes and biochemical processes (for a recent ex-
ample using complementary techniques, see Stumberger et al.
2016). However, until very recently, the isolation of marine mi-
crobes and their gene products using classical cultivation meth-
ods and biochemistry was work-intensive and time-consuming.
Today,molecular technology has reached ahigh level of sophisti-
cation and has enabled a quantum leap in our knowledge of the
marine microbial world (Salazar and Sunagawa 2017). The es-
tablishment of international consortia and ocean sampling cam-
paigns to exploremarinemicrobial diversity has contributed sig-
nificantly to this technological breakthrough. In addition to our
growing knowledge on the scales of marine microbial diversity,
we are also gaining a clearer insight into the basis for themolec-
ular adaptation of microorganisms to diverse conditions. This
is associated with our increasing knowledge on the diversity
of microbial gene products and how they contribute to regulat-
ing the metabolic state under diverse conditions (Glo¨ckner et al
2012). This can include, for example, the recruitment of alternate
pathways for carbon cycling and innovations across metabolic
sub-systems and the tree of life by maximising growth rate, effi-
ciency and evolutionary progress, favouring genome minimisa-
tion and streamlining (Braakman and Smith 2014). From a more
applied point of view, microbial enzymes represent tools for
biotechnological processes, some of whichmay find their way to
industry (Costessi et al. 2018) and commercialisation (Sherkow
2017). In this article, we discuss the accumulated knowledge
on marine microbial assemblages; the factors that have lim-
ited their screening and use as a source of novel enzymes and
other gene products; and the importance of improving our un-
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Figure 1. Phylogenetic tree representing the diversity of marine species spanning across the three domains of life. The figure represents the all-species living tree,
release 132 (Yarza et al. 2010; Munoz et al. 2011), including all sequenced type strains belonging to the Archaea and Bacteria. The microorganisms of marine origin are
shown in the outermost ring with grey lines. The tree comprises 13 903 leaves, from which 469 belong to microbial species isolated from marine environments. Major
taxonomic clusters are highlighted by colours (see the legend). The scale bar represents the number of changes per site. The indications in the outer circle point the
species from which full genome sequence, draft genome and/or with reviewed proteins in Swiss-Prot are available.
GENOMES AND ENZYMES OF MARINE
MICROORGANISMS
The assessment of microbial diversity for all kingdoms of
life on Earth, based on the World Register of Marine Species
(WORMS) (www.marinespecies.org), predicts the existence of
∼8.7 ± 1.3 million species globally, of which ∼2.2 ± 0.18 mil-
lion are marine species. In 2011, about 91% of the species
(mostly eukaryotes) in the ocean still awaited description
(Mora et al. 2011). Restricting this prediction to prokaryote
taxa resulted in at least ∼1.3 million species in the world’s
oceans, of which about half have been catalogued. The taxo-
nomic census of all species present in the most recent release
of the Living Tree Project database (Yarza et al. 2010) reflects
the high diversity of cultured marine microorganisms (Fig. 1).
The assessment of microbial diversity for all marine micro-
bial genomes, regardless of the level of completeness based on
MarDB (https://mmp.sfb.uit.no/databases/mardb/), may give an
indication of marine microbial species with cultivable represen-
tatives for which genome sequence information is available. Un-
derstanding and analysing these genetic resourcesmay not only
help in understandingmarinemicrobial ecology and adaptation
mechanisms, but could also provide a source of novel enzymes.
The current version of the SILVA rRNA database project
(release 132, www.arb-silva.de) contains sequence information
for manually curated complete or partial genomes of about
8 900 cultured marine microorganisms (Fig. 1). Based on UniProt
Knowledgebase (UniProtKB) (www.uniprot.org/), one can further
gain estimates on thosemarinemicrobes with available genome
sequences from which enzymatic biochemical knowledge has
also been catalogued. This can be seen in Fig. 1, which shows
that proteins from cultured and genome-sequenced marine mi-
crobial representatives, belonging to ∼173 genera, have been
catalogued in UniProtKB. This biochemical knowledge is also
limited since in ∼57% of those cases, less than 10 enzymes
have been retrieved. This represents a global picture of a gen-
eral paucity of biochemical knowledge about marine microbes.
Considering the estimated diversity of prokaryotic species in the
global ocean, approximately 1.3 million, only fewmicrobes have
been screened for their enzymes, whose number is also low. Mi-
crobial and enzymatic technologies are currently not a limiting
factor in the advancement of new applications of marine micro-
bial products in industrial biotechnology. The critical constraint
on the path of making progress is that we are still far from cata-
loguing ourmicrobial and,more important, our enzymatic biore-
sources to find those that can be further investigated for use in
industry.
MARINE METAGENOMES
One of the most extensive global surveys of microbial diver-
sity to date was carried out by the Earth Microbiome Project
(http://www.earthmicrobiome.org/); it has gained information
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Units (OTUs) present in at least 15 000 samples. Extrapolating
this genetic information to the level of proteins has been less
successful, with almost no information available about enzymes
associated with those OTUs. A similar situation was observed
after examining available data compiled from marine circum-
navigation ocean sampling expeditions. Some examples are as
follows: the Sargasso Sea Expeditions (https://www.mbari.org/
at-sea/expeditions/sargasso-sea-expeditions), the Sorcerer II
Global Ocean Sampling Expedition (https://www.jcvi.org/gos),
Tara Oceans (https://www.embl.de/tara-oceans/start/research/
index.html), Malaspina (http://www.expedicionmalaspina.es/),
Galathea 3 (http://www.galathea3.dk/uk.html), Global Ocean
Sampling Expedition (https://www.ncbi.nlm.nih.gov/books/
NBK6855/), as well as many other smaller scale expeditions
(https://www.ebi.ac.uk/metagenomics/). These expeditions
have collected and analysed hundreds of thousands of samples,
resulting in a profusion of information about the 16S rRNA
gene sequences and expansion of our appreciation of micro-
bial biodiversity. However, associated information about the
inherent functional biochemistry is rather scarce. This dispar-
ity between taxonomic and biochemical information can be
explained mainly by recent advances in sequencing technology,
allowing for large-scale, inexpensive and fast sequencing of
uncultured biodiversity, with the most rate-limiting step in
this process being the bioinformatic analysis. Unlocking the
biochemical or biotechnological potential of these sequences,
however, requires laborious wet lab work, including extensive
cloning of genes of interest, followed by the expression and
characterisation of enzymes. This is not a trivial exercise, given
that not all genes in a metagenome assembly are full length
or can be successfully cloned and expressed. The choice of
methodology for enzyme discovery between genomic data
predictions and naı¨ve enzyme screening approaches remains
open. Naı¨ve screens allow identification of genes encoding
enzymes with functions that were not known to humankind
earlier, but sequencing followed by in silico predictions allows us
to increase the speed of discovery, regardless of the novelty of
the enzymes. Of course, it should be stressed that novelty itself
does not guarantee better enzymatic performance and better
opportunities of commercialisation.
ENZYMES: FROM DISCOVERY TO
MANUFACTURING
Cataloguing and characterising microbial and enzymatic diver-
sity is tedious and time-consuming. Thus, about 11 000 mi-
crobial species from cultivable representatives, including ma-
rine species, have been properly described and deposited in
databases (Yarza et al. 2010, 2014). At the current rate of circa
600 new descriptions annually, it is expected that cataloguing
all predicted microbial species will take at least another 1000
years. If these predictions are extrapolated to enzymes, the time
framewill be evenmore extensive. At the present discovery rate,
it would take about 1 million years to sequence all microbial
genomes, retrieve the information of sequences encoding en-
zymes and further characterise them. This is without consider-
ing the analysis of enzymes encoded by sequences annotated as
hypotheticals.
In addition, not all microbial products require the same time
frame for discovery and marketing. Thus, based on the ex-
perience of Pharma Mar, S.A., the world’s leading biopharma-
ceutical company in the discovery of marine-derived oncology
drugs, it takes about 15–20 years to discover and commercialise
one bioactive microbial product for clinical applications, from a
starting number of several thousands of pre-selected analogues.
The total cost of all the needed steps, including discovery, pre-
clinical and clinical studies and approval, and sales, may reach
up to ∼US$802 million, with only two out of five molecules re-
covering the cost. In the case of bulk enzymes for applications
in different market sectors, this time frame is shorter, but still
challenging froman industrial perspective. Actually, it is difficult
to estimate the time frame needed to discover and produce each
marketable enzyme, but real examples on the web (http://www.
biocatalysts.com/enzyme-development-manufacture/) suggest
the following: 1 week for investigating whether a continuous
supply of a novel enzyme at right price can allow running a
manufacturing process; an undetermined time to find the right
enzyme by applying bioinformatics, cloning and metagenomics
technologies; 11 weeks for selecting and producing at a scale of
0.5–1 g best 20 candidates for testing; 8 to 12 weeks for delivering
a sample of active and soluble enzyme with technical specifica-
tions; 8 to 12 weeks for proving that the enzyme performs well
under manufacturing conditions so that it fits into commercial
requirements; and 30 weeks for producing a standard enzyme
product applying a validated, regulated and quality-assured rou-
tine manufacturing process. This accounts for at least 58–66
weeks plus the undetermined time, a priory challenging to be
predicted, needed to screen the untapped biological diversity in
the microbial world, including marine bioresources, to find the
right enzymes. It is important to mention that the average cost
of commercial enzymes is about US$400/kg, and that although
estimations of the total cost for all the needed steps, includ-
ing discovery, cloning, expression, characterisation, biocatalysis
studies and approval, and sales, are difficult to make, a mini-
mum cost of US$10 000 is expected.
INMARE: A EUROPEAN COLLABORATION
PROVIDING A FASTER ROUTE TO
IDENTIFICATION OF LEAD PRODUCTS
Research and development arising from large sampling ex-
peditions, microbial cultivation efforts, and genome and
metagenome sequencing have paved the way for future work
in the field of enzymology and microbial-associated functions.
However, there is a significant gap in knowledge related to the
large-scale analysis of enzyme activities in microorganisms, in-
cluding marine ones. There is a need to invest an effort to de-
code the enzyme content of marine microorganisms, indepen-
dent of their amenability to cultivation. The understanding of
cultured or uncultured marine microorganisms that encode en-
zymes with broad or narrow substrate spectra, higher or lower
levels of chiral selectivity, solvent-resistance or solvent-activity
and stability, and low- or high-pH/temperature activity is of in-
creasing demand. Having this information framed in the context
of some larger scale processes, such as carbon cycling and pro-
ductivity, would help in articulating the relevance of enzymes
in the context of microbial ecology and of biogeochemical cy-
cles that underpin the functioning of marine ecosystems, and
ultimately the Earth’s biosphere. Additionally, compiling more
information on marine enzymes will provide new biocatalysts
for future developments and help in predicting enzyme proper-
ties from accumulated biochemical data. Advancing our knowl-
edge in these areas can be most effectively addressed through
the collaboration of academic/research institutes and indus-
trial partners, particularly those already leading the process of
streamlining and shortening pipelines of the gene product (en-
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Table 1. Pipeline representing the technical solutions provided by INMARE to significantly shorten the timeneeded fromdiscovery to application
in different technological levels.
Technologies to be implemented
Technology readiness
levels (TRL)1 Principal activities
(i) Commercialisation
(ii) Intellectual properties rights protection
TRL 9 (i) Novel enzymatic applications
(ii) Novel biocatalytic processes
Business interaction TRL 8
Testing of candidates under real process
conditions
TRL 7 Scale-up application and pilot-scale process
Enzyme collection: characterization and
optimization
TRL 6 Enzyme candidates all-rounders
(i) High-quality crystallisation and structural
analysis facilities
(ii) Bioanalytical and bioprocess engineering
facilities and expertise
TRL 5 Secondary screening and enzyme engineering
High-edge sequence annotation pipeline and
bioinformatics resources
TRL 4 Pre-characterised enzyme library—candidate set
Innovative enzyme screening assays and
platforms
TRL 3 Sequence and activity-based screening
State-of-art technologies for the construction of
metagenomics libraries
TRL 2 Metagenomic and genomic libraries
Advanced technologies to access and sample
unique marine biodiversity hotspots
TRL 1 Unique marine biodiversity resources
1TRL 9: system proven in operational environment; TRL 8: system completed and qualified; TRL 7: system prototype demonstration in operational environment; TRL
6: technology demonstrated in industrially relevant environment; TRL 5: technology validated in industrially relevant environment; TRL 4: technology validated in lab;
TRL 3: experimental proof of concept; TRL 2: technology concept formulated; TRL 1: basic principles observed.
With these objectives, a pan-European consortium of part-
ners was established in 2015 to work together on the EU project
‘INMARE’ (Industrial Application of Marine Enzymes). Funded
by the EU Horizon 2020 Research and Innovation Programme,
INMARE aims to explore marine biodiversity in diverse environ-
ments to find novel enzymes to meet the needs of the growing
industrial enzyme market. Led by Bangor University in Wales
and comprising 24 multidisciplinary academic and industrial
partners from 12 countries, the 4-year INMARE project adopted a
multifaceted approach to achieve its aims, which is summarised
in Table 1. It focused on samples isolated from already known
or novel biodiversity hotspots (hypersaline, thermophilic, sub-
surface, deep-sea, low-pH vents, etc.). It has established in vitro
and in vivo screening platforms to identify relevant gene prod-
ucts, as well as constructing sequence analysis pipelines to
target enzymes of industrial relevance—thus streamlining the
identification of genes of interest from sequence data. Associat-
ing unknown sequences with enzyme activities of interest was
also a priority, given that most sequence databases are full of
sequences encoding genes with unknown functions. Producing
biocatalytic data was a key priority, which required expanding
the spectrum of hosts for heterologous protein expression, thus
shortening the cumbersome phase of enzyme optimisation by
testing enzyme candidates under application conditions at the
very early discovery phase. Finally, INMARE has increased our
ability to analyse and compare biocatalytic data from highly di-
verse enzymes to predict more rapidly functions from sequenc-
ing data. This involved identifying enzymeswith appropriate ac-
tivity phenotypes by screening a large enzyme collection against
arrays of a few hundred compounds representing challenging
chemical steps in real applications, resulting in shortlisting pri-
ority targets, as well as understanding enzyme properties and
ways to predict them. Engineering and immobilisation, which
are important issues for industrial applications of enzymes, are
the activities also covered within the project. The innovation
comes not only by the technical developments but also by the
application of a pipeline, which covers all steps from discovery
to the end use. Only by screening a large diversity of marine
microbes producing a large repertoire of marine enzymes, one
can guarantee deciphering the ocean’s microbial microbiome in
a frame with biotechnology advances.
In its first phase, INMARE has contributed, through the devel-
opment of advanced methods for biotechnological blueprinting
of marine microbes, to the creation of one of the largest collec-
tions of genomic and metagenomic enzymes, with the focus on
those most requested at the industrial level. Currently, this col-
lection accounts for about 1000 enzymes, of which circa 94% are
available in ready-to-use expression systems and 32% have been
fully characterised (see, for recent examples, Popovic et al. 2017
and Martı´nez-Martı´nez et al. 2018).
These enzymes are quite diverse and non-redundant in
terms of their amino acid sequences and geographical distribu-
tion and taxonomic origin (Fig. 2). They demonstrate a sequence
identity of as low as 5% compared to sequences in databases
and comprise enzymes from at least 193 geographically distinct
sites, at least 283 known bacterial and archaeal genera, and ap-
proximately 607 microorganisms with unclear taxonomic affili-
ations. Condensing and streamlining the arduous phase of the
optimisation process allowed the identification of lead products
and prototypes with potential for IP protection and fast com-
mercialisation. This can be achieved through subjecting enzyme
candidates to multiple tests to assess their industrial applica-
bility at the earliest stages of discovery, and to stabilisation by
engineering and immobilisation and testing using conditions to
mimic those required by industry.
OUTLOOK
Ocean’s microbial diversity remains undersampled and poorly
understood. Microbiology, molecular biology, biochemical and
bioprocess technologies are diverse, but all need to be further
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Figure 2. Phylogenetic tree representing the diversity of studied enzymes spanning the three domains of life. The database used for the reconstruction corresponds
to the release number 132 from the non-redundant SILVA database for the small sub-unit of the ribosomal RNA (September 2018). Phyla (or corresponding rank for
the Eukaryotes) containing the characterised enzymes are depicted in colour (yellow for Eukaryotes, blue for Archaea and red for Bacteria). The graphs represent the
families for which enzymes have been characterised (coloured cells) and the total number of families within the phylum according to the SILVA taxonomy (level D4
for taxonomic family). Bigger squares contain 10 × 10 units to allow easier visualisation. The number of genera with INMARE enzymes indicated for each coloured
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innovation through industrially relevant research and develop-
ment can be fast-tracked. The project has achieved more than it
aimed to in terms of developing innovative screening and pro-
cessingmethodologies, the use of which can and will drastically
shorten the laborious industrial enzyme screening and optimi-
sation steps. The INMARE success is clearly illustrated by the
fact that in less than 3 years, the INMARE partnership has cata-
logued and characterised the most comprehensive collection of
marine genomic and metagenomic enzymes worldwide, some
of which currently outperform the best commercial prototypes.
INMARE demonstrates the importance and effectiveness of the
European collaboration and the role of the European Union’s
Horizon 2020 Research and Innovation Programme in driving
innovation.
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